Literature DB >> 34951951

The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand still.

Aaron W Michels1, Maria J Redondo2, Mark A Atkinson3.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34951951      PMCID： PMC9201938          DOI： 10.1016/S2213-8587(21)00344-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   44.867


× No keyword cloud information.
  10 in total

Review 1.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment.

Authors:  M A Atkinson; G S Eisenbarth
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

Review 2.  Type I diabetes mellitus. A chronic autoimmune disease.

Authors:  G S Eisenbarth
Journal:  N Engl J Med       Date:  1986-05-22       Impact factor: 91.245

3.  Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes.

Authors:  Manuela Battaglia; Simi Ahmed; Mark S Anderson; Mark A Atkinson; Dorothy Becker; Polly J Bingley; Emanuele Bosi; Todd M Brusko; Linda A DiMeglio; Carmella Evans-Molina; Stephen E Gitelman; Carla J Greenbaum; Peter A Gottlieb; Kevan C Herold; Martin J Hessner; Mikael Knip; Laura Jacobsen; Jeffrey P Krischer; S Alice Long; Markus Lundgren; Eoin F McKinney; Noel G Morgan; Richard A Oram; Tomi Pastinen; Michael C Peters; Alessandra Petrelli; Xiaoning Qian; Maria J Redondo; Bart O Roep; Desmond Schatz; David Skibinski; Mark Peakman
Journal:  Diabetes Care       Date:  2019-11-21       Impact factor: 19.112

4.  State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.

Authors:  Nicole C Foster; Roy W Beck; Kellee M Miller; Mark A Clements; Michael R Rickels; Linda A DiMeglio; David M Maahs; William V Tamborlane; Richard Bergenstal; Elizabeth Smith; Beth A Olson; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2019-01-18       Impact factor: 6.118

Review 5.  Type 1 diabetes.

Authors:  Linda A DiMeglio; Carmella Evans-Molina; Richard A Oram
Journal:  Lancet       Date:  2018-06-16       Impact factor: 79.321

Review 6.  A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries.

Authors:  Zulfiqar A Bhutta; Rehana A Salam; Apoorva Gomber; Laura Lewis-Watts; Tanya Narang; Jean Claude Mbanya; George Alleyne
Journal:  Lancet       Date:  2021-11-13       Impact factor: 79.321

Review 7.  Type 1 diabetes.

Authors:  Mark A Atkinson; George S Eisenbarth; Aaron W Michels
Journal:  Lancet       Date:  2013-07-26       Impact factor: 79.321

Review 8.  Technology in the management of type 1 diabetes mellitus - current status and future prospects.

Authors:  Martin Tauschmann; Roman Hovorka
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

Review 9.  Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.

Authors:  Richard A Insel; Jessica L Dunne; Mark A Atkinson; Jane L Chiang; Dana Dabelea; Peter A Gottlieb; Carla J Greenbaum; Kevan C Herold; Jeffrey P Krischer; Åke Lernmark; Robert E Ratner; Marian J Rewers; Desmond A Schatz; Jay S Skyler; Jay M Sosenko; Anette-G Ziegler
Journal:  Diabetes Care       Date:  2015-10       Impact factor: 19.112

10.  Etiology of Autoimmune Islet Disease: Timing Is Everything.

Authors:  Åke Lernmark
Journal:  Diabetes       Date:  2021-06-21       Impact factor: 9.461
  10 in total
  2 in total

Review 1.  Stem cell-based multi-tissue platforms to model human autoimmune diabetes.

Authors:  Karla F Leavens; Juan R Alvarez-Dominguez; Linda T Vo; Holger A Russ; Audrey V Parent
Journal:  Mol Metab       Date:  2022-10-06       Impact factor: 8.568

Review 2.  Self-Antigens Targeted by Regulatory T Cells in Type 1 Diabetes.

Authors:  Angela M Mitchell; Aaron W Michels
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.